A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer

Name: A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer
License: Public Domain

Jazz Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

her2+/hr+ breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208458
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.